54 193 (Viramune 200 mg)
Generic Name: nevirapine
Pill imprint 54 193 has been identified as Viramune 200 mg.
Viramune is used in the treatment of hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Viramune 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 54 193
- 200 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00054-0459||Roxane Laboratories, Inc.|
|54868-3844||Physicians Total Care Inc (repackager)|
|54569-4561||A-S Medication Solutions, LLC (repackager)|
|55289-0392||PDRX Pharmaceuticals Inc (repackager)|
|35356-0071||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Viramune (nevirapine)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.